drugset / Trial / NCT01964183
Post-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of Tolterodine
NaSingle-groupOpen-label
Summary
To assess the effect of multiple doses of mirabegron to postmenopausal adult female subjects on the pharmacokinetics (PK) of tolterodine and its metabolites. In addition, the safety of these products will be assessed.
Timeline
- Start
- 2013-06
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirabegron | Other / unclassified | — | Oral |
| Subject | Tolterodine | Unknown | — | Oral |
Indications
No indication recorded.